Familial hypertrophic cardiomyopathy. Cardiac ultrasonic abnormalities in genetically affected subjects without echocardiographic evidence of left ventricular hypertrophy

European Heart Journal

Volumn 19, Issue 3, 1998, Pages 490-499

  Hagege A A ^a   Dubourg, O ^b   Desnos, M ^a   Mirochnik, R ^a   Isnard, G ^d   Bonne, G ^c   Carrier, L ^c   Guicheney, P ^c   Bouhour, J B ^e   Schwartz, K ^f   Komajda, Michel ^d  

^a Hopital Boucicaut   (France)

^b HÔPITAL AMBROISE PARÉ   (France)

^c INSERM   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e CHU de Nantes   (France)

^f Grp Hosp Pitie Salpetriere ^*

Author keywords

MHC gene; Echocardiography; Genetics; Hypertrophic cardiomyopathy; MyPB C gene

Indexed keywords

MYOSIN HEAVY CHAIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BODY HEIGHT; CHILD; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GENE MUTATION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE WALL; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; RELATIVE; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; FEMALE; HEART VENTRICLES; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MUTATION; PHENOTYPE;

EID: 0032032248     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1997.0735     Document Type: Article

References (42)

1. [1] Schwartz K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation 1995; 91: 532-40.
2. [2] Marian AJ, Roberts R.Recent advances in the molecular genetics of hypertrophic cardiomyopathy. Circulation 1995; 92: 1336-47.
3. [3] Geisterfer-Lowrance AAT, Kass S, Tanogawa G, et al. A molecular basis for familial hypertrophic cardiomyopathy: a β-cardiac myosin heavy chain gene missense mutation. Cell 1990; 62: 999-1996.
4. [4] Jarcho JA, McKenna W, Peter Pare JA et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14ql. N Engl J Med 1989; 321: 1372-8.
5. [5] Watkins H, MacRae C, Thierfelder L et al. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3. Nature genet 1993; 3: 333-7.
6. [6] Thierfelder L, MacRae C, Watkins H. et al. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2. Proc Natl Acad Sci USA 1993; 90: 6270-4.
7. [7] Carrier L, Hengstenberg C, Beckman JS et al. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11. Nature genet 1993; 4: 311-4.
8. [8] Watkins HC, McKenna WJ, Thierfelder LH et al. Mutations in the genes for cardiac troponin T and α-tropomyosin in hypertrophic cardiomyopathy. N Engl J Med 1995; 332: 1058-64.
9. [9] Bonne G, Carrier L, Bercovici J, et al. Cardiac myosin binding protein-C gene splice acceptor site mutation is associated with familial hypertrophic cardiomyopathy. Nature genet 1995; 11: 438-40.
10. [10] Watkins H, Conner D, Thierfelder L et al. Mutations in the cardiac myosin binding protein gene on chromosome 11 cause familial hypertrophic cardiomyopathy. Nature genet 1995; 11: 434-7.
11. [11] McRae CA, Ghaisas N, Kass S. et al. Familial hypertrophic cardiomyopathy with Wolff-Parkinson-White syndrome maps to a locus on chromosome 7q3.. J Clin Invest 1995; 96: 1216-20.
12. [12] Hengstenberg C, Charron P, Isnard R. et al. Mise en évidence d'un cinquième locus impliqué dans les cardiomyopathies hypertrophiques familiales. Arch Mal Coeur 1994; 87: 1655-62.
13. [13] Maron BJ, Bonow RO, Canon III RO, Leon MB, Epstein SE. Hypertrophic cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy. N Engl J Med 1987; 316: 780-9/844-52.
14. [14] Solomon SD, Wolff S, Watkins H et al. Left ventricular hypertrophy and morphology in familial hypertrophic cardiomyopathy associated with mutations of the beta-myosin heavy chain. J Am Coll Cardiol 1993; 22: 498-505.
15. [15] Keating M.Molecular echocardiography (Editorial). J Am Coll Cardiol 1993; 22: 506-7.
16. [16] Maron BJ, Spirito P, Wesley Y, Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med 1986; 315: 610-14.
17. [17] Charron P, Dubourg O, Desnos M et al. Diagnostic value of electrocardiography and echocardiography in genetically affected adults with familial hypertrophic cardiomyopathy. Circulation 1997; 96: 214-19.
18. [18] Fananapazir L, Epstein ND. Prevalence of hypertrophic cardiomyopathy and limitations of screening methods. Circulation 1995; 92: 700-4.
19. [19] Dausse E, Komajda M, Fetler L. et al. Familial Hypertrophic cardiomyopathy: micro satellite haplotyping and identification of a hot-spot for mutations in the β-myosin heavy chain gene. J Clin Invest 1993; 92: 2807-13.
20. [20] Rosenzweig A, Watkins H, Hwang DS et al. Preclinical diagnosis of familial hypertrophic cardiomyopathy by genetic analysis of blood lymphocytes. N Engl J Med 1991; 325: 1573-60.
21. [21] McKenna WJ, Stewart JT, Nihoyannopoulos P, McGinty F, Davies MJ. Hypertrophic cardiomyopathy without hypertrophy: two families with myocardial disarray in the absence of increased myocardial mass. Br Heart J 1990; 63: 287-90.
22. [22] Fananapazir L, Epstein N. Genotype-phenotype correlations in hypertrophic cardiomyopathy: Insights provided by comparisons of kindreds with distinct and identical β-myosin heavy chain gene mutations. Circulation 1994; 89: 22-32.
23. [23] Epstein ND, Cohn GM, Cyran F, Fananapazir L. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the β-myosin heavy chain gene: a 908 Leu → Val mutation and a 403 Arg → Glu mutation. Circulation 1992; 86: 345-52.
24. [24] Dubourg O, Isnard R, Hagège A, et al. Doppler echocardiography in familial hypertrophic cardiomyopathy: the French Cooperative Study. Echocardiography 1995; 12: 235-41.
25. [25] Al-Mahdawi S, Chamberlain S, Chojnowska L et al. The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene. Br Heart J 1994; 72: 105-11.
26. [26] Schwartz K, Beckmann J, Dufour C et al. Exclusion of cardiac myosin heavy chain and actin gene involvement in hypertrophic cardiomyopathy of several French families. Circ Res 1992; 71: 3-8.
27. [27] Sahn DJ, DeMaria A, Kisslo J, Weyman A. The committee on M-mode standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
28. [28] Henry WL, Ware J, Gardin JM, Hepner SL, McKay J, Weiner M.. Echocardiographic measurements in normal subjects: growth-related changes that occur between infancy and early adulthood. Circulation 1978; 57: 278-82.
29. [29] Teicholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic-angiographic correlations in the presence of asynergy. Am J Cardiol 1976; 37: 7-11.
30. [30] Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613-18.
31. [31] Reichek N, Wilson J, St John Sutton M, Plappert TA, Goldberg S, Hirshfeld JW. Noninvasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation 1982; 65: 99-109.
32. [32] Borow KN, Green LH, Grossman W, Braunwald E. Left ventricular end-systolic stress-shortening and stress length relations in humans. Normal values and sensitivity to inotropic state. Am J Cardiol 1982; 50: 1301-8.
33. [33] Maron BJ, Kragel AH, Roberts WC. Sudden death in hypertrophic cardiomyopathy with normal left ventricular mass. Br Heart J 1990; 63: 308-10.
34. [34] Wigle ED, Sasson Z, Henderson MA et al. Hypertrophic cardiomyopathy: the importance of the site and extent of hypertrophy-a review. Prog Cardiovasc Dis 1985; 28: 1-83.
35. [35] Klues HG, Schiffers A, Maron BJ. Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: Morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients. J Am Coll Coll Cardiol 1995; 26: 1699-708.
36. [36] Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983; 2: 437-44.
37. [37] Keating M. Risk, genotype, and cardiovascular disease. Circulation 1992; 86: 688-90.
38. [38] Cuda G, Sellers J, Epstein ND, Fananapazir L. In vitro motility activity of β-cardiac myosin depends on the nature of the β-myosin heavy chain gene mutation in hypertrophic cardiomyopathy. Circulation 1993; 38 (Suppl I): I-343.
39. [39] Sweeney HL, Straceski AJ, Leinwand LA, Tikunov BA, Faust L. Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction. J Biol Chem 1994; 269: 1603-5.
40. [40] Jiang L, Levine RA, King ME, Weyman AE. An integrated mechanism to explain the systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy based on echocardiographic observations. Am Heart J 1997; 113: 633-44.
41. [41] Klues HG, Maron BJ, Dollar AL, Roberts WC. Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 1992; 85: 1651-61.
42. [42] Lechin M, Quinones MA, Omran A. et al. Converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995; 92: 1808-12.